These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8737142)

  • 1. In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori.
    Koga T; Kawada H; Utsui Y; Domon H; Ishii C; Yasuda H
    J Antimicrob Chemother; 1996 May; 37(5):919-29. PubMed ID: 8737142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo.
    Koga T; Inoue H; Ishii C; Okazaki Y; Domon H; Utsui Y
    J Antimicrob Chemother; 2002 Jul; 50(1):133-6. PubMed ID: 12096020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo.
    Sasaki M; Mizoshita T; Mizushima T; Inoue H; Kamiya T; Kataoka H; Ogaswara N; Wada T; Kubota E; Mori Y; Shimura T; Hirata H; Ando K; Okamoto Y; Ohara H; Nakao H; Joh T
    J Antimicrob Chemother; 2007 Nov; 60(5):1060-3. PubMed ID: 17827146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal effect of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori.
    Koga T; Kawada H; Utsui Y; Domon H; Ishii C; Yasuda H
    J Antimicrob Chemother; 1996 Sep; 38(3):387-97. PubMed ID: 8889714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of plaunotol with bacterial membranes.
    Koga T; Watanabe H; Kawada H; Takahashi K; Utsui Y; Domon H; Ishii C; Narita T; Yasuda H
    J Antimicrob Chemother; 1998 Aug; 42(2):133-40. PubMed ID: 9738829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of plaunotol derivatives and their antibacterial activities against Helicobacter pylori.
    Tago K; Minami E; Masuda K; Akiyama T; Kogen H
    Bioorg Med Chem; 2001 Jul; 9(7):1781-91. PubMed ID: 11425580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plaunotol suppresses interleukin-8 secretion induced by Helicobacter pylori: therapeutic effect of plaunotol on H. pylori infection.
    Takagi A; Koga Y; Aiba Y; Kabir AM; Watanabe S; Ohta-Tada U; Osaki T; Kamiya S; Miwa T
    J Gastroenterol Hepatol; 2000 Apr; 15(4):374-80. PubMed ID: 10824880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro anti-microbial activity against H. pylori and clinical efficacy of various drugs].
    Fujioka T; Kawasaki H; Su WW; Nasu M
    Nihon Rinsho; 1993 Dec; 51(12):3255-60. PubMed ID: 8283643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anti-ulcer agents on antibiotic activity against Helicobacter pylori.
    Sunairi M; Watanabe K; Suzuki T; Tanaka N; Kuwayama H; Nakajima M
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S121-4. PubMed ID: 7735928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The susceptibility of Campylobacter pylori to antiulcer agents and antibiotics.
    Nagate T; Numata K; Hanada K; Kondo I
    J Clin Gastroenterol; 1990; 12 Suppl 1():S135-8. PubMed ID: 2212539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Plaunotol].
    Ito S; Azuma T; Yamazaki Y
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():693-7. PubMed ID: 11979873
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibacterial activity of teprenone, a non water-soluble antiulcer agent, against Helicobacter pylori.
    Ishii E
    Zentralbl Bakteriol; 1993 Sep; 280(1-2):239-43. PubMed ID: 8280947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori.
    Fukuda Y; Yamamoto I; Okui M; Tonokatsu Y; Tamura K; Shimoyama T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S45-7. PubMed ID: 8574735
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Xu YF; Lian DW; Chen YQ; Cai YF; Zheng YF; Fan PL; Ren WK; Fu LJ; Li YC; Xie JH; Cao HY; Tan B; Su ZR; Huang P
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly stereoselective synthesis of plaunotol and its thiourea derivatives as potent antibacterial agents against Helicobacter pylori.
    Kogen H; Tago K; Arai M; Minami E; Masuda K; Akiyama T
    Bioorg Med Chem Lett; 1999 May; 9(10):1347-50. PubMed ID: 10360733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori.
    Iwao E; Yamamoto K; Yokoyama Y; Hirayama F; Haga K
    J Infect Chemother; 2004 Apr; 10(2):90-6. PubMed ID: 15160301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micro-broth dilution method with air-dried microplate for determining MICs of clarithromycin and amoxycillin for Helicobacter pylori isolates.
    Kobayashi I; Muraoka H; Saika T; Nishida M; Fujioka T; Nasu M
    J Med Microbiol; 2004 May; 53(Pt 5):403-406. PubMed ID: 15096549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Helicobacter pylori potential of artemisinin and its derivatives.
    Goswami S; Bhakuni RS; Chinniah A; Pal A; Kar SK; Das PK
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4594-607. PubMed ID: 22687518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Helicobacter pylori activities of Chenopodium ambrosioides L. in vitro and in vivo.
    Ye H; Liu Y; Li N; Yu J; Cheng H; Li J; Zhang XZ
    World J Gastroenterol; 2015 Apr; 21(14):4178-83. PubMed ID: 25892867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.